{"id":5649,"date":"2025-03-23T13:27:52","date_gmt":"2025-03-23T13:27:52","guid":{"rendered":"https:\/\/agderma.de\/?p=5649"},"modified":"2025-03-23T13:29:40","modified_gmt":"2025-03-23T13:29:40","slug":"variability-in-triple-bottom-line-commitments-of-multinational-pharmaceutical-and-cosmeceutical-companies-insights-from-2023-corporate-and-esg-reports","status":"publish","type":"post","link":"https:\/\/agderma.de\/fr\/presse\/2025\/variability-in-triple-bottom-line-commitments-of-multinational-pharmaceutical-and-cosmeceutical-companies-insights-from-2023-corporate-and-esg-reports\/","title":{"rendered":"Variabilit\u00e9 dans les engagements triple bottom line des multinationales pharmaceutiques et cosm\u00e9tiques : enseignements tir\u00e9s des rapports 2023 de la soci\u00e9t\u00e9 et des rapports ESG"},"content":{"rendered":"<h2 class=\"wp-block-heading\" id=\"509160929\">R\u00e9sum\u00e9<\/h2>\n\n\n\n<p>La triple base est un cadre d'\u00e9valuation de la performance organisationnelle int\u00e9grant les impacts environnementaux, sociaux et \u00e9conomiques. Cette \u00e9tude a examin\u00e9 les engagements de la triple base de multinationales op\u00e9rant dans le domaine de la dermatologie avec un accent particulier sur les objectifs environnementaux. Un \u00e9chantillon de 10 entreprises pharmaceutiques et de 6 entreprises cosm\u00e9tiques a \u00e9t\u00e9 inclus dans cette \u00e9tude. Nous avons effectu\u00e9 une analyse r\u00e9trospective des donn\u00e9es secondaires de leurs rapports annuels 2023 publi\u00e9s et de leurs rapports environnementaux, sociaux et de gouvernance (ESG), et avons examin\u00e9 leurs engagements. Les r\u00e9sultats montrent que toutes les entreprises, \u00e0 l'exception de 3 entreprises pharmaceutiques (81% ; 13\/16), ont publi\u00e9 une ann\u00e9e cible pour atteindre un bilan carbone net nul ou neutre pour les GHG scopes 1 et 2 (ann\u00e9e m\u00e9diane = 2040 ; fourchette = 2025-2050 ; 95% intervalle de confiance (IC) = 2035-2045). Toutes les entreprises sauf 4 pharmaceutiques (75% ; 12\/16) ont publi\u00e9 une ann\u00e9e cible pour atteindre le carbone net z\u00e9ro ou la neutralit\u00e9 pour le GHG scope 3 (ann\u00e9e m\u00e9diane = 2043 ; intervalle 2026-2050 ; 95% CI = 2038-2047). Tous les plans de neutralit\u00e9 nette ou carbone identifi\u00e9s ont indiqu\u00e9 l'inclusion potentielle ou l'utilisation effective de syst\u00e8mes de compensation carbone ou d'\u00e9limination du carbone dans la r\u00e9alisation de leurs objectifs. Toutes les entreprises, sauf une (84.4% ; 5\/6), font partie du consortium EcoBeauty. Cette \u00e9tude a mis en \u00e9vidence la variabilit\u00e9 de leurs ambitions en mati\u00e8re d'objectifs environnementaux.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>&gt;&gt; Article disponible sur <a href=\"https:\/\/doi.org\/10.1093\/ced\/llaf133\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1093\/ced\/llaf133<\/a> &lt;&lt;<\/p>\n\n\n\n<p>Rebecca Grant, Dennis Niebel, William Hunt, Members of the British Association of Dermatologists Sustainability Subcommittee , Simon Tso, Variability in Triple Bottom Line commitments of Multinational Pharmaceutical and Cosmeceutical Companies : Insights from 2023 Corporate and ESG Reports,\u00a0<em>Dermatologie clinique et exp\u00e9rimentale<\/em>, 2025 ;, llaf133,\u00a0<a href=\"https:\/\/doi.org\/10.1093\/ced\/llaf133\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1093\/ced\/llaf133<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Article disponible sur https:\/\/doi.org\/10.1093\/ced\/llaf133<\/p>","protected":false},"author":1,"featured_media":5650,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[10],"tags":[],"class_list":["post-5649","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-presse"],"acf":[],"_links":{"self":[{"href":"https:\/\/agderma.de\/fr\/wp-json\/wp\/v2\/posts\/5649","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/agderma.de\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/agderma.de\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/agderma.de\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/agderma.de\/fr\/wp-json\/wp\/v2\/comments?post=5649"}],"version-history":[{"count":3,"href":"https:\/\/agderma.de\/fr\/wp-json\/wp\/v2\/posts\/5649\/revisions"}],"predecessor-version":[{"id":5654,"href":"https:\/\/agderma.de\/fr\/wp-json\/wp\/v2\/posts\/5649\/revisions\/5654"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/agderma.de\/fr\/wp-json\/wp\/v2\/media\/5650"}],"wp:attachment":[{"href":"https:\/\/agderma.de\/fr\/wp-json\/wp\/v2\/media?parent=5649"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/agderma.de\/fr\/wp-json\/wp\/v2\/categories?post=5649"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/agderma.de\/fr\/wp-json\/wp\/v2\/tags?post=5649"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}